Clinical Trials · NCT07740291

Tirzepatide Impact Assessment Study

RecruitingN/ATirzepatide (Investigational)Semaglutide (Investigational)
Phase
N/A
Recruitment status
Recruiting
Sponsor
Texas Tech University
Enrollment
27
Start date
Jan 2025
Locations
1 site, United States
Primary endpoint
Change in Fasting Blood Glucose
View Tirzepatide compound reference